Global Markets

Merck (MRK GY) to buy Silence Therapeutics for USD 20/ADS in cash

StockNow breaking-news AI analysis

The headline reports Merck’s proposed cash purchase of Silence Therapeutics at USD 20 per ADS; no article text is available to confirm further terms.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more